Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities
Abstract Significant advances in the development of new cancer therapies have given rise to multiple novel therapeutic options in chemotherapy, radiotherapy, immunotherapy, and targeted therapies. Although the development of resistance is often reported along with temporary disease remission, there...
Saved in:
| Main Authors: | Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202403936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-cell analysis of the epitranscriptome: RNA modifications under the microscope
by: Eva Crespo-García, et al.
Published: (2024-12-01) -
Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease
by: Esther Ugo Alum, et al.
Published: (2025-08-01) -
Epitranscriptomics and cervical cancer: the emerging role of m6A, m5C and m1A RNA modifications
by: Akshat D. Modi, et al.
Published: (2024-01-01) -
Unraveling the dual role of METTL3-mediated m6A RNA modification in bladder cancer: mechanisms, therapeutic vulnerabilities, and clinical implications
by: Hua Chun, et al.
Published: (2025-12-01) -
Molecular mechanisms of m6A modifications regulating tumor radioresistance
by: Ruolin Shen, et al.
Published: (2025-02-01)